NO970317L - Anvendelse av DHA i en farmasöytisk blanding - Google Patents
Anvendelse av DHA i en farmasöytisk blandingInfo
- Publication number
- NO970317L NO970317L NO970317A NO970317A NO970317L NO 970317 L NO970317 L NO 970317L NO 970317 A NO970317 A NO 970317A NO 970317 A NO970317 A NO 970317A NO 970317 L NO970317 L NO 970317L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- dha
- pharmaceutical composition
- sec
- fatty acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9510636.5A GB9510636D0 (en) | 1995-05-25 | 1995-05-25 | Fatty acid treatment |
PCT/GB1996/001265 WO1996037200A1 (en) | 1995-05-25 | 1996-05-24 | Use of dha as a pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970317D0 NO970317D0 (no) | 1997-01-24 |
NO970317L true NO970317L (no) | 1997-01-24 |
Family
ID=10775045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970317A NO970317L (no) | 1995-05-25 | 1997-01-24 | Anvendelse av DHA i en farmasöytisk blanding |
Country Status (17)
Country | Link |
---|---|
US (1) | US6150411A (xx) |
EP (1) | EP0774962B1 (xx) |
JP (1) | JPH10503531A (xx) |
KR (1) | KR970704433A (xx) |
AT (1) | ATE264676T1 (xx) |
AU (1) | AU722474B2 (xx) |
CA (1) | CA2195979A1 (xx) |
DE (1) | DE69632236T2 (xx) |
DK (1) | DK0774962T3 (xx) |
ES (1) | ES2217317T3 (xx) |
FI (1) | FI970298A0 (xx) |
GB (1) | GB9510636D0 (xx) |
HK (1) | HK1012575A1 (xx) |
NO (1) | NO970317L (xx) |
PT (1) | PT774962E (xx) |
WO (1) | WO1996037200A1 (xx) |
ZA (1) | ZA964215B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1326344A (zh) * | 1998-10-15 | 2001-12-12 | Dsm公司 | Pufa增补剂 |
KR100341109B1 (ko) * | 1999-03-10 | 2002-06-20 | 이인수 | 인식력 및 기억력 증강용 식이 조성물 |
US7112609B2 (en) * | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
GB9918023D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
US6479545B1 (en) * | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
DE60220415T2 (de) | 2001-07-27 | 2008-02-14 | Neptune Technologies & Bioressources Inc., Laval | Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
TWI365716B (en) * | 2003-12-02 | 2012-06-11 | Suntory Holdings Ltd | Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same |
JP2007524674A (ja) * | 2004-01-19 | 2007-08-30 | マーテック・バイオサイエンシーズ・コーポレーション | リーリン欠損症または機能障害およびそれに関連する方法 |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
GB0813599D0 (en) * | 2008-07-24 | 2008-09-03 | Pharma Marine As | Method |
PT2493478T (pt) | 2009-10-29 | 2018-04-03 | Acasti Pharma Inc | Composições terapêuticas concentradas de fosfolípidos |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
MX2018014140A (es) * | 2016-06-01 | 2019-02-25 | Nestec Sa | Composicion para usar en la profilaxis de enfermedades alergicas. |
WO2023102170A1 (en) * | 2021-12-02 | 2023-06-08 | The Regents Of The University Of California | Compositions and methods for inhibiting seizures |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
-
1995
- 1995-05-25 GB GBGB9510636.5A patent/GB9510636D0/en active Pending
-
1996
- 1996-05-24 AU AU58277/96A patent/AU722474B2/en not_active Ceased
- 1996-05-24 KR KR1019970700488A patent/KR970704433A/ko active IP Right Grant
- 1996-05-24 ZA ZA964215A patent/ZA964215B/xx unknown
- 1996-05-24 PT PT96919911T patent/PT774962E/pt unknown
- 1996-05-24 EP EP96919911A patent/EP0774962B1/en not_active Expired - Lifetime
- 1996-05-24 DE DE69632236T patent/DE69632236T2/de not_active Expired - Fee Related
- 1996-05-24 WO PCT/GB1996/001265 patent/WO1996037200A1/en active IP Right Grant
- 1996-05-24 ES ES96919911T patent/ES2217317T3/es not_active Expired - Lifetime
- 1996-05-24 AT AT96919911T patent/ATE264676T1/de not_active IP Right Cessation
- 1996-05-24 JP JP8535515A patent/JPH10503531A/ja not_active Ceased
- 1996-05-24 CA CA002195979A patent/CA2195979A1/en not_active Abandoned
- 1996-05-24 DK DK96919911T patent/DK0774962T3/da active
- 1996-05-24 US US08/776,250 patent/US6150411A/en not_active Expired - Lifetime
-
1997
- 1997-01-24 FI FI970298A patent/FI970298A0/fi unknown
- 1997-01-24 NO NO970317A patent/NO970317L/no not_active Application Discontinuation
-
1998
- 1998-12-18 HK HK98113985A patent/HK1012575A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO970317D0 (no) | 1997-01-24 |
PT774962E (pt) | 2004-09-30 |
DE69632236T2 (de) | 2005-04-14 |
EP0774962B1 (en) | 2004-04-21 |
AU722474B2 (en) | 2000-08-03 |
DE69632236D1 (de) | 2004-05-27 |
FI970298A (fi) | 1997-01-24 |
ZA964215B (en) | 1996-12-04 |
DK0774962T3 (da) | 2004-08-09 |
HK1012575A1 (en) | 1999-08-06 |
JPH10503531A (ja) | 1998-03-31 |
EP0774962A1 (en) | 1997-05-28 |
KR970704433A (ko) | 1997-09-06 |
AU5827796A (en) | 1996-12-11 |
US6150411A (en) | 2000-11-21 |
GB9510636D0 (en) | 1995-07-19 |
CA2195979A1 (en) | 1996-11-28 |
ATE264676T1 (de) | 2004-05-15 |
WO1996037200A1 (en) | 1996-11-28 |
FI970298A0 (fi) | 1997-01-24 |
ES2217317T3 (es) | 2004-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970317D0 (no) | Anvendelse av DHA i en farmasöytisk blanding | |
DE69317433D1 (de) | Ungesättigte aliphatische dicarbonsäuren | |
ID21473A (id) | Sediaan farmasi yang mengandung asam eikosapentanoat dan asam stearidonat | |
DE68905863D1 (de) | Zusammensetzungen essentieller fettsaeuren. | |
ATE216230T1 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
BG102011A (en) | 1,3-propane diol derivatives as bioactive compounds(21) 102012 (22) 31.10.97 (13) l (19) bg (41) 29.05.98 (51) 6c 07 d 209/28 a (51) 6c 07 d 339/04 b (51) 6a 61 k 31/23 b (51) 6c 07 c 69/587 b (51) 6c 07 c 69/767 b (86) pct/gb96/01052,01.05.96 (87) wo96/34855,07.11.96 (31) 9508823 (32) 01.05.95 (33) gb (31) 9517107 (32) 21.08.95 (33) gb (31) 9605440 (32) 15.03.96 (33) gb (71) gb scotia holdings plc (72) gb horrobin, david f. (72) gb manku, mehar (72) gb mcmordie, austin (72) gb knowles, phillip (72) gb redden, peter (72) gb pitt, andrea (74) olga ruseva sirakova, (74) 1124 sofija,kompl."javorov",bl.19,vkh.g (54) fatty acid esters as bioactive compounds | |
MY110765A (en) | Compositions containing cholesteryl esters of unsaturated fatty acids | |
DE69409969D1 (de) | Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen | |
HK37694A (en) | Fatty acids compositions | |
EP0850068A4 (en) | LIPID EXTRACT WITH ANTI-INFLAMMATORY ACTIVITY | |
KR910007858A (ko) | 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산 | |
PT920323E (pt) | Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica | |
ATE192647T1 (de) | Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung. | |
AU6346586A (en) | Therapeutic agents | |
ATE120954T1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids. | |
AU1821888A (en) | Treatment or prevention of memory loss using essential fatty acid compositions | |
NZ306510A (en) | Niacin derivatives which include a fatty acid or fatty acid alcohol residue and their use in medicaments and skin care compositions | |
ES2124395T3 (es) | Utilizacion de esteres de diglicerina contra las impurezas de la piel. | |
ATE175344T1 (de) | Gelbildende präparate, die optisch angereicherte gelbildner enthalten | |
ATE86108T1 (de) | Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen. | |
ATE63684T1 (de) | Deodorant. | |
DK0599967T3 (da) | Opspaltning af arylalkansyrer. | |
DE59202373D1 (en) | N-acyl-phosphatidylethanolamin als oxidationsschutzmittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |